Genetic typing and prevalence of Border disease virus (BDV) in small ruminant flocks in Spain.
Between 2001 and 2002, samples from 1,413 animals in 21 Spanish small ruminant flocks, most of them with animals showing clinical signs compatible with Border disease (BD), were screened for the presence of Pestivirus antigen and antibodies by an indirect peroxidase monolayer assay (IPMA) and the virus neutralization test (VNT), respectively. Although all flocks harboured seropositive animals, virus could only be isolated from animals in five of the flocks. Between 4 and 11 months later all animals older than 6 months in three of the flocks were resampled. At this time, 51-83% of them had neutralizing antibodies. The prevalence of persistently infected (PI) animals within two of the flocks was 0.3 and 0.6%, respectively. The third flock presumably had eliminated all the PI animals. Fourteen virus isolates were obtained. The 5' untranslated region (5'UTR) was amplified by RT-PCR and directly sequenced. Phylogenetic analyses classified them as a group of Border disease viruses (BDV), separated from BDV-1, but showing a relatively low bootstrap value. Three of the 14 isolates were in the same subgroup as a set of formerly characterised Spanish isolates from the Basque Country, which were allocated to subgroup BDV-C. In addition, they were in the group with an isolate from chamois, which is currently allocated in group BDV-4. Because of its close relation to the chamois isolate, these isolates were tentatively reallocated in a subgroup BDV-4a. The remaining isolates generated a new subgroup, related but not in the same cluster as the chamois isolate, and was therefore tentatively assigned to a new subgroup BDV-4b. Our results show that classification and nomenclature of BDV needs to be harmonised.
Valdazo-González
B
B
Departamento de Patología Animal, Sanidad Animal, Facultad de Veterinaria, Universidad de León, León, Spain.
Alvarez-Martínez
M
M
Greiser-Wilke
I
I
D020121:5' Untranslated Regions; D000367:Age Factors; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D000956:Antigens, Viral / Q000276:immunology; D001882:Border Disease / Q000453:epidemiology* / Q000821:virology; D018083:Border disease virus / Q000145:classification* / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D005260:Female; D005784:Gene Amplification; D006041:Goats; D007124:Immunoenzyme Techniques / Q000662:veterinary; D008297:Male; D009500:Neutralization Tests / Q000662:veterinary; D010802:Phylogeny; D012367:RNA, Viral / Q000032:analysis*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D048608:Rupicapra; D016036:Seroepidemiologic Studies; D012756:Sheep; D013030:Spain / Q000453:epidemiology; D013045:Species Specificity
D020121:5' Untranslated Regions; D000914:Antibodies, Viral; D000956:Antigens, Viral; D012367:RNA, Viral